Dicle Üniversitesi Hastaneleri
- Research works
- 13 ▼ 49% vs 2018-21
- Citations
- 31 2.4 per fractional work
- Top-10% rate
- 1.6% all institutions 10.0%
- Open access
- 79% world 40%
- International
- 4% world 18%
Not ranked overall: Dicle Üniversitesi Hastaneleri is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Dicle Üniversitesi Hastaneleri work in?
In all years, 63% of research at Dicle Üniversitesi Hastaneleri is in Health Sciences, 17% in Social Sciences. Its largest fields are Medicine (57%), Biochemistry, Genetics and Molecular Biology (7%), Arts and Humanities (6%). It does 1.9× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 14 fields, with their numbers
- Health Sciences863.2%
- Medicine757.1%
- Health Professions14.4%
- Nursing01.7%
- Social Sciences216.9%
- Arts and Humanities16.4%
- Social Sciences14.4%
- Economics, Econometrics and Finance02.5%
- Psychology02.3%
- Decision Sciences01.3%
- Life Sciences216.0%
- Physical Sciences03.8%
- Engineering02.5%
- Environmental Science01.3%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Dicle Üniversitesi Hastaneleri publish most on?
By volume in 2022-now: Multiple Sclerosis Research Studies, Potassium and Related Disorders, Drug-Induced Adverse Reactions and Electroconvulsive Therapy Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 0 works
- 2 Potassium and Related Disorders Pulmonary and Respiratory Medicine 0 works
- 3 Drug-Induced Adverse Reactions Pharmacology 0 works
- 4 Electroconvulsive Therapy Studies Psychiatry and Mental health 0 works
- 5 Epilepsy research and treatment Psychiatry and Mental health 0 works
- 6 Liver Disease Diagnosis and Treatment Epidemiology 0 works
- 7 Autoimmune and Inflammatory Disorders Epidemiology 0 works
- 8 Pharmacological Effects and Toxicity Studies Pediatrics, Perinatology and Child Health 0 works
- 9 Hormonal and reproductive studies Endocrinology, Diabetes and Metabolism 0 works
- 10 Sexual function and dysfunction studies Psychiatry and Mental health 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Dicle Üniversitesi Hastaneleri's research output changed?
Output in 2022-2025 was 49% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Dicle Üniversitesi Hastaneleri as a percentage of every work published that year, 0.0000036% in 2024.
Fractional works of Dicle Üniversitesi Hastaneleri over all fractional works that year. How the balance of science has shifted.
Other research institutions in Diyarbakır
- Dicle University
- Diyarbakır Gazi Yaşargil Eğitim ve Araştırma Hastanesi
- Ergani Devlet Hastanesi
- Diyarbakır Askeri Hastanesi
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Dicle Üniversitesi Hastaneleri. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.